New study aims to predict survival in respiratory care units

NCT ID NCT07644637

Not yet recruiting Knowledge-focused Sponsor: Hospital Universitari de Bellvitge Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will collect data from 624 patients in respiratory intermediate care units (RICUs) across Catalonia to build a model that predicts 30-day survival. Researchers will also test an artificial intelligence approach and create a quick app for doctors. The goal is to better understand which patients benefit most from RICU care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could give doctors a reliable tool to predict which patients will benefit most from a respiratory intermediate care unit, potentially improving survival and resource use.
What could go wrong: This is an observational study, not a treatment trial. The model may not work as well in other hospitals or may not change patient outcomes in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY FAILURE (ARF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute respiratory failure pulmonary embolism thoracic cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE RESPIRATORY FAILURE (ARF) INTERMEDIATE RESPIRATORY CARE UNIT MORTALITY PREDICTION RESPIRATORY PRECISION MEDICINE STRATIFICATION RISK

Contacts and locations

Locations

Respiratory Department. Hospital Universitari de Bellvitge

L'Hospitalet de Llobregat, Barcelona, 08907, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.